10.6084/m9.figshare.c.3661721_D5.v1
Lixia Gao
Lixia
Gao
Xuli Wang
Xuli
Wang
Yaoliang Tang
Yaoliang
Tang
Shuang Huang
Shuang
Huang
Chien-An Hu
Chien-An
Hu
Yong Teng
Yong
Teng
Additional file 3: Figure S3. of FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib
Springer Nature
2017
FGF19
FGFR4
Hepatocellular carcinoma
Drug resistance
Sorafenib
Synergistic effect
2017-01-09 05:00:00
Figure
https://springernature.figshare.com/articles/figure/Additional_file_3_Figure_S3_of_FGF19_FGFR4_signaling_contributes_to_the_resistance_of_hepatocellular_carcinoma_to_sorafenib/4534733
FGFR4 overexpression does not chance sorafenib-induced cell response. (A–E) The effect of FGFR4 overxpression on Sora-induced HCC cell apoptosis and ROS generation. FGFR4 overexpressing MHCC97H cells (FGFR4 O/E) were treated with 4 μM of Sora over a series of time points before analysis. Cell viability was determined by MTS assays (A); cell apoptosis was determined by DAPI staining (B) and Western blot (C); ROS generation was determined by DCFH-DA staining (D); and O2 •− generation was determined by electrochemical biosensor (E). In (C), expression levels were normalized against actin and reported relative to controls (fold changes shown below each lane). (TIF 1164 kb)